Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomePicarroPicarro Announces Family of Products for Measuring Ethylene Oxide

Picarro Announces Family of Products for Measuring Ethylene Oxide

Picarro announces a family of Ethylene Oxide (C2H4O) Gas Concentration Analyzers, capable of measuring this hazardous air pollutant in real-time with detection limits of parts-per-trillion (ppt). These analyzers enable services providers, regulators and researchers access to accurate and effortless measurements of Ethylene Oxide (EtO), thus minimizing and preventing exposure of humans and the environment to this toxic gas.

While the mutagenic properties of EtO have been known since the 1940s, the regulatory landscape around emissions and exposure limits has evolved over time. Today it is an important chemical used for the sterilization of medical equipment and a common ingredient in the industrial production of other compounds. EtO is now believed to be more harmful than previously realized and a leap in analytical instrumentation is required to better characterize the risk to workers and communities.

The EtO family of analyzers represents a monumental advancement in measurement and monitoring technology, and is realized by a refinement of Picarro’s existing Cavity Ring-Down Spectroscopy (CRDS) platform. Once focused on measurements of sharp spectral signatures of simple molecules (e.g. CO2 and CH4), the technology is now able to resolve complex spectral signatures at limits of detection (LOD) that are orders of magnitude better than traditional methods such as FTIR and GC. The remarkable stability, performance and ease-of-use of the platform, adopted over the years by the world’s most demanding research organizations, now provides an exciting alternative to a market in desperate need of disruptive technology.

The EtO family of analyzers is available as three standalone products. The G2910 Stack and Indoor Air Quality Analyzer introduces technical services companies to the most sensitive (<250 ppt LOD), interference free, real-time measurement of EtO concentrations, enabling new measurement opportunities and more efficient deployments. The G2920 Fugitive Analyzer introduces the measurement community to a platform that supports long-term monitoring of emissions at the fenceline. Performance standards set by expensive, difficult to use, research-grade instruments (e.g. PTR-MS) are overshadowed by this easy-to-deploy technology with best-in-class LOD (<100 ppt). The G2930 Ambient Analyzer represents the greatest improvement in EtO detection (<25 ppt LOD) and meets an ambitious goal of protecting communities from long-term exposure to EtO. Continuous monitoring removes unknowns that arise from data gaps, and lack of flask sampling and analysis.

“If we want to limit industrial emissions of ethylene oxide and understand how fugitive emissions impact public health, we need to first be able to measure how EtO disperses and persists in our environment,” said Joel Avrunin, VP of Scientific Instrumentation. “We are pleased to introduce a solution that gives previously unavailable insight to support industry and our communities in this task.”

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy